A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.
SELLAS Life Sciences CEO Angelos Stergiou and "Some Future Day" author Marc Beckman predict artificial intelligence will ...
Here’s why doctors recommend getting specific shots at specific times — as well as what happens when parents stray from that ...
With 90 to 95 per cent of cervical cancer cases caused by the human papillomavirus (HPV), vaccination offers a nearly 99 per cent protection rate against the disease. Prince Court Medical Centre ...
A new initiative, led by the Indian Medical Association (IMA) and the Federation of Obstetric and Gynaecological Societies of ...
The firm said it has received positive feedback from the FDA on the design of a Phase III trial of ELI-002 in KRAS-mutant pancreatic cancer.
Vaccines are helpful in protecting against the flu and COVID-19, but could they also play a role in the fight against cancer?
Chemoablation with mitomycin gel (Jelmyto) for low-grade upper tract urothelial cancer led to a 3-year recurrence-free ...
R.F.K. Jr. and others have blamed the ingredient for allergies and other illnesses. Scientists say it actually bolsters the ...
The Alabama Department of Public Health reports that there are 14,000 new HPV cases annually and 4,000 women die from the disease each year.
Vaccines are helpful in protecting against the flu and COVID-19, but could they also play a role in the fight against cancer?
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback